2rrs: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{STRUCTURE_2rrs| PDB=2rrs | SCENE= }} | {{STRUCTURE_2rrs| PDB=2rrs | SCENE= }} | ||
===NMR Structure of LC4 transmembrane segment of CCR5=== | ===NMR Structure of LC4 transmembrane segment of CCR5=== | ||
{{ABSTRACT_PUBMED_21647380}} | |||
==Disease== | |||
[[http://www.uniprot.org/uniprot/CCR5_HUMAN CCR5_HUMAN]] Genetic variation in CCR5 is associated with susceptibility to diabetes mellitus insulin-dependent type 22 (IDDM22) [MIM:[http://omim.org/entry/612522 612522]]. A multifactorial disorder of glucose homeostasis that is characterized by susceptibility to ketoacidosis in the absence of insulin therapy. Clinical features are polydipsia, polyphagia and polyuria which result from hyperglycemia-induced osmotic diuresis and secondary thirst. These derangements result in long-term complications that affect the eyes, kidneys, nerves, and blood vessels.<ref>PMID:19073967</ref> | |||
==Function== | |||
[[http://www.uniprot.org/uniprot/CCR5_HUMAN CCR5_HUMAN]] Receptor for a number of inflammatory CC-chemokines including MIP-1-alpha, MIP-1-beta and RANTES and subsequently transduces a signal by increasing the intracellular calcium ion level. May play a role in the control of granulocytic lineage proliferation or differentiation. Acts as a coreceptor (CD4 being the primary receptor) for HIV-1 R5 isolates.<ref>PMID:8639485</ref><ref>PMID:8663314</ref><ref>PMID:8699119</ref><ref>PMID:8649511</ref><ref>PMID:8649512</ref><ref>PMID:11323418</ref> | |||
==About this Structure== | ==About this Structure== | ||
| Line 22: | Line 13: | ||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID:021647380</ref><references group="xtra"/> | <ref group="xtra">PMID:021647380</ref><references group="xtra"/><references/> | ||
[[Category: Miyamoto, K.]] | [[Category: Miyamoto, K.]] | ||
[[Category: Ccr5]] | [[Category: Ccr5]] | ||